Skip to main content

Table 2 Validity estimates for MacroH2A1.1 and QKI expression levels as diagnostic biomarkers for prostate cancer identification

From: Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype

Parameter

MacroH2A1.1 performance

DDX5 performance

DDX17 performance

QKI performance

Sensitivity (%)

80.7

82.7

47.3

88.8

Specificity (%)

93.3

93.3

93.3

93.3

Accuracy (%)

81.6

83.5

50.5

88.7

Positive likelihood ratio (LR+)

12.04

12.34

7.06

13.25

Negative likelihood ratio (LR−)

0.21

0.19

0.56

0.12

AUC (95% IC)

p value

0.92 (0.876–0.965)

p < 0.0001

0.65 (0.549–0.751)

p = 0.0533

0.93 (0.872–0.980)

p < 0.0001

0.94 (0.897–0.987)

p < 0.0001